Spanu A, Chessa F, Battista Meloni G, Sanna D, Cottu P, Manca A, Nuvoli S, Madeddu G
Department of Nuclear Medicine, University of Sassari, Sassari, Italy.
Q J Nucl Med Mol Imaging. 2009 Apr;53(2):133-43. Epub 2008 Apr 25.
The aim of this study was to compare preoperative planar scintimammography (SM) with high resolution dedicated breast camera (DBC) and conventional mammography in the detection of multifocal, multicentric and bilateral breast cancer and its impact on surgical planning.
A series of 264 consecutive patients, 232 with breast cancer and 32 with benign lesions, underwent [(99m)Tc]tetrofosmin planar SM with a newly developed DBC (LumaGEM 3200S/12K, Gamma Medica-Ideas Inc.). Scintigraphic with mammography data were compared and correlated with histopathological findings.
At surgery, ipsilateral multifocal or multicentric breast cancer in 40 patients, invasive in 24 cases (group 1) and in situ in 16 (group 2) was ascertained, and synchronous bilateral breast cancer in 4 patients (group 3). Globally, SM was positive for cancer in 41 out of the 44 breast cancer patients (93.2%) and mammography was positive in 40 out of 44 (90.1%). SM revealed multifocal/multicentric disease in 87.5% of group 1/goup 2 patients and mammography in 47.5% (P<0.0005): SM detected a significantly higher number of additional invasive foci than mammography (89.6% vs 37.9%, P<0.0005); only SM revealed ipsilateral multifocality/multicentricity in 35% of cases. Bilaterality was detected by SM in 100% of group 3 patients and by mammography in 75%. Overall specificity was 88.2% for SM and 52.9% for mammography. SM correctly changed surgical management in 16% of cases.
DBC planar SM proved a more highly sensitive diagnostic method than mammography in the preoperative assessment of both ipsilateral multifocal/multicentric breast cancer and synchronous bilateral breast cancer. The procedure contributed to correctly changing patient surgical management in some cases, suggesting its wider use complementary to mammography.
本研究旨在比较术前平面乳腺闪烁显像(SM)、高分辨率专用乳腺相机(DBC)和传统乳腺钼靶在检测多灶性、多中心性和双侧乳腺癌方面的效果及其对手术规划的影响。
连续264例患者,其中232例患有乳腺癌,32例患有良性病变,使用新开发的DBC(LumaGEM 3200S/12K,Gamma Medica-Ideas公司)进行[(99m)Tc]替曲膦平面SM检查。将闪烁显像与乳腺钼靶数据进行比较,并与组织病理学结果相关联。
手术时,确定40例患者存在同侧多灶性或多中心性乳腺癌,其中24例为浸润性(第1组),16例为原位癌(第2组),4例患者存在同步双侧乳腺癌(第3组)。总体而言,44例乳腺癌患者中41例(93.2%)的SM检查结果为癌症阳性,44例中40例(90.1%)的乳腺钼靶检查结果为阳性。SM检查显示第1组/第2组患者中87.5%存在多灶性/多中心性疾病,乳腺钼靶检查显示为47.5%(P<0.0005):SM检查发现的额外浸润灶数量明显多于乳腺钼靶检查(89.6%对37.9%,P<0.0005);仅SM检查发现35%的病例存在同侧多灶性/多中心性。第3组患者中,SM检查发现双侧性的比例为100%,乳腺钼靶检查为75%。SM检查的总体特异性为88.2%,乳腺钼靶检查为52.9%。SM检查在16%的病例中正确改变了手术管理方式。
在术前评估同侧多灶性/多中心性乳腺癌和同步双侧乳腺癌方面,DBC平面SM检查被证明是一种比乳腺钼靶更敏感的诊断方法。该检查方法在某些情况下有助于正确改变患者的手术管理方式,表明其可作为乳腺钼靶检查的补充更广泛地应用。